Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Patricia L. Henegan is active.

Publication


Featured researches published by Patricia L. Henegan.


Toxins | 2015

Detection of cyanotoxins, β-N-methylamino-L-alanine and microcystins, from a lake surrounded by cases of amyotrophic lateral sclerosis.

Sandra Anne Banack; Tracie A. Caller; Patricia L. Henegan; James F. Haney; Amanda Murby; James S. Metcalf; James T. Powell; Paul Alan Cox; Elijah W. Stommel

A cluster of amyotrophic lateral sclerosis (ALS) has been previously described to border Lake Mascoma in Enfield, NH, with an incidence of ALS approximating 25 times expected. We hypothesize a possible association with cyanobacterial blooms that can produce β-N-methylamino-l-alanine (BMAA), a neurotoxic amino acid implicated as a possible cause of ALS/PDC in Guam. Muscle, liver, and brain tissue samples from a Lake Mascoma carp, as well as filtered aerosol samples, were analyzed for microcystins (MC), free and protein-bound BMAA, and the BMAA isomers 2,4-diaminobutyric acid (DAB) and N-(2-aminoethyl)glycine (AEG). In carp brain, BMAA and DAB concentrations were 0.043 μg/g ± 0.02 SD and 0.01 μg/g ± 0.002 SD respectively. In carp liver and muscle, the BMAA concentrations were 1.28 μg/g and 1.27 μg/g respectively, and DAB was not detected. BMAA was detected in the air filters, as were the isomers DAB and AEG. These results demonstrate that a putative cause for ALS, BMAA, exists in an environment that has a documented cluster of ALS. Although cause and effect have not been demonstrated, our observations and measurements strengthen the association.


Epilepsy & Behavior | 2016

A cognitive behavioral intervention (HOBSCOTCH) improves quality of life and attention in epilepsy.

Tracie A. Caller; Robert J. Ferguson; Robert M. Roth; Karen Secore; Faith P. Alexandre; Wenyan Zhao; Tor D. Tosteson; Patricia L. Henegan; Kimberly Birney; Barbara C. Jobst

OBJECTIVE Cognitive difficulties in epilepsy are common and add to disability beyond seizures alone. A self-management intervention targeting cognitive dysfunction was developed and assessed for whether it improves quality of life, objective memory, and mood in adults with epilepsy. METHODS The HOme Based Self-management and COgnitive Training CHanges lives (HOBSCOTCH) program was developed to incorporate (1) psychoeducation, (2) self-awareness training, (3) compensatory strategies, and (4) application of these strategies in day-to-day life using problem solving therapy. Adults aged 18-65 years with epilepsy (n=66) were randomized into 3 groups, to receive 8 weeks of HOBSCOTCH, with (H+) or without (H) additional working memory training on a commercial gaming device, or to a waitlisted control group. The primary outcome was quality of life (Quality of Life in Epilepsy scale, QOLIE-31) with secondary outcomes of objective cognition measured with the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) and depression (as measured by PHQ9 and NDDIE). RESULTS Both intervention arms showed a significant improvement in quality of life, as compared with controls who demonstrated a decline in QOLIE-31 scores. There was significant improvement in objective cognitive performance among the intervention groups, most notably in attention, compared with the waitlisted controls. There was no significant change in depression scores. SIGNIFICANCE The HOBSCOTCH program significantly improved quality of life and appeared to be an effective intervention to address cognitive dysfunction in adults with epilepsy. Further studies are needed to assess the generalizability and cost-effectiveness of this intervention.


Neurodegenerative Diseases | 2017

Environmental and Occupational Exposures and Amyotrophic Lateral Sclerosis in New England

Angeline S. Andrew; Tracie A. Caller; Rup Tandan; Eric J. Duell; Patricia L. Henegan; Nicholas C. Field; Walter G. Bradley; Elijah W. Stommel

Background: Recent data provide support for the concept that potentially modifiable exposures are responsible for sporadic amyotrophic lateral sclerosis (ALS). Objective: To evaluate environmental and occupational exposures as risk factors for sporadic ALS. Methods: We performed a case-control study of ALS among residents of New England, USA. The analysis compared questionnaire responses from 295 patients with a confirmed ALS diagnosis to those of 225 controls without neurodegenerative illness. Results: Self-reported job- or hobby-related exposure to one or more chemicals, such as pesticides, solvents, or heavy metals, increased the risk of ALS (adjusted OR 2.51; 95% CI 1.64-3.89). Industries with a higher toxicant exposure potential (construction, manufacturing, mechanical, military, or painting) were associated with an elevated occupational risk (adjusted OR 3.95; 95% CI 2.04-8.30). We also identified increases in the risk of ALS associated with frequent participation in water sports, particularly waterskiing (adjusted OR 3.89; 95% CI 1.97-8.44). Occupation and waterskiing both retained independent statistical significance in a composite model containing age, gender, and smoking status. Conclusions: Our study contributes to a growing body of literature implicating occupational- and hobby-related toxicant exposures in ALS etiology. These epidemiologic study results also provide motivation for future evaluation of water-body-related risk factors.


Neurodegenerative Diseases | 2015

The Epidemiology of Amyotrophic Lateral Sclerosis in New Hampshire, USA, 2004-2007

Tracie A. Caller; Angeline Andrews; Nicholas C. Field; Patricia L. Henegan; Elijah W. Stommel

Background/Aims: Trends in disease incidence and mortality can provide clues to disease etiology. Previously, we described a town in New Hampshire (N.H.), USA, with 25 times the expected incidence rate of amyotrophic lateral sclerosis (ALS). This study aimed to describe the incidence and mortality of ALS across the state to assess rates relative to other states and industrialized nations. Method: A retrospective review of records from regional ALS centers, clinics and ALS organizations was conducted to obtain demographics and diagnostic details for patients diagnosed with ALS or primary lateral sclerosis in N.H. from January 2004 to December 2007. Data on mortality from review of death certificates were obtained for a similar time frame. Results: We identified 113 N.H. residents diagnosed with ALS in 2004-2007, yielding an age-standardized incidence rate ranging from 1.3 to 2.2 per 100,000 of the population per year. During the same period, the standardized mortality rate per 100,000 varied from 2.6 to 3.5. ALS was more common among men (ratio 1.6:1), who were more likely than women to have an earlier age at onset (59 ± 14.2 vs. 65 ± 11.8 years, p = 0.01). Conclusion: While localized areas in N.H. with high ALS incidence rates have been reported previously, the overall incidence and mortality rates of ALS in N.H. are similar to those in other industrialized nations.


Epilepsy & Behavior | 2015

Design and feasibility of a memory intervention with focus on self-management for cognitive impairment in epilepsy.

Tracie A. Caller; Karen Secore; Robert J. Ferguson; Robert M. Roth; Faith P. Alexandre; Patricia L. Henegan; Jessica J. Harrington; Barbara C. Jobst

The aim of this study was to assess the feasibility of a self-management intervention targeting cognitive dysfunction to improve quality of life and reduce memory-related disability in adults with epilepsy. The intervention incorporates (1) education on cognitive function in epilepsy, (2) self-awareness training, (3) compensatory strategies, and (4) application of these strategies in day-to-day life using problem-solving therapy. In addition to the behavioral modification, formal working memory training was conducted by utilizing a commercially available program in a subgroup of patients. Our findings suggest that a self-management intervention targeting cognitive dysfunction was feasible for delivery to a rural population with epilepsy, with 13 of 16 enrolled participants completing the 8-session program. Qualitative data indicate high satisfaction and subjective improvement in cognitive functioning in day-to-day life. These findings provide support for further evaluation of the efficacy of this intervention through a randomized controlled trial.


Neurotoxicity Research | 2018

The Potential Role of BMAA in Neurodegeneration

Tracie A. Caller; Patricia L. Henegan; Elijah W. Stommel

Neurodegenerative diseases are a major public health issue throughout the world with devastating effects on patients and families. Sporadic forms of neurodegenerative diseases such as Alzheimer’s disease, Parkinson’s disease, and amyotrophic lateral sclerosis are generally thought to develop as a consequence of genetic susceptibility and environmental influences. A number of environmental triggers have been identified in association with amyotrophic lateral sclerosis and Parkinson’s disease. We discuss the role of β-methylamino-l-alanine in the development of neurodegeneration and the potential importance of this neurotoxin as a risk for neurodegeneration.


Neurotoxicity Research | 2018

Erratum to: Assessing Cyanobacterial Harmful Algal Blooms as Risk Factors for Amyotrophic Lateral Sclerosis

Nathan Torbick; Beth Ziniti; Elijah W. Stommel; Ernst Linder; Angeline S. Andrew; Tracie A. Caller; Jim Haney; Walter G. Bradley; Patricia L. Henegan; Xun Shi

The article “Assessing Cyanobacterial Harmful Algal Blooms as Risk Factors for Amyotrophic Lateral Sclerosis”, written by Nathan Torbick, was originally published electronically on the publisher’s internet portal (currently SpringerLink) on May 13, 2017 without open access. With the author(s)’ decision to opt for Open Choice the copyright of the article changed on September 18, 2017 to


Journal of Alzheimers Disease & Parkinsonism | 2016

The Potential Role of BMAA in Neurodegeneration: Amyotrophic LateralSclerosis, AlzheimerâÂÂs Disease and Parkinsonism

Tracie A. Caller; Patricia L. Henegan; Elijah W. Stommel

Neurodegenerative diseases are a major public health issue throughout the world with devastating effects on patients and families alike. Sporadic forms of neurodegenerative diseases such as Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis are generally thought to develop as a consequence of genetic susceptibility and environmental influences. A number of environmental triggers have been identified in association with amyotrophic lateral sclerosis and Parkinson’s disease. We discuss the role of β-methylamino L-alanine in the development of neurodegeneration and the potential importance of this neurotoxin as a risk for neurodegeneration.


Neurotoxicity Research | 2018

Assessing Cyanobacterial Harmful Algal Blooms as Risk Factors for Amyotrophic Lateral Sclerosis

Nathan Torbick; Beth Ziniti; Elijah W. Stommel; Ernst Linder; Angeline S. Andrew; Tracie A. Caller; Jim Haney; Walter G. Bradley; Patricia L. Henegan; Xun Shi


Neurology | 2015

Possible Environmental Causes of Amyotrophic Lateral Sclerosis in Northern New England: A Preliminary Analysis (P4.142)

Tracie Caller; Patricia L. Henegan; Angeline S. Andrew; Elijah W. Stommel

Collaboration


Dive into the Patricia L. Henegan's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Robert J. Ferguson

Eastern Maine Medical Center

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Angeline S. Andrew

Dartmouth–Hitchcock Medical Center

View shared research outputs
Top Co-Authors

Avatar

Beth Ziniti

University of New Hampshire

View shared research outputs
Top Co-Authors

Avatar

Ernst Linder

University of New Hampshire

View shared research outputs
Top Co-Authors

Avatar

Jim Haney

University of New Hampshire

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge